Language is one of several barriers to inclusivity in clinical trials. In this Vistatec webinar, Citeline’s Lya Rebelo joins panelists in discussing ways to address this challenge.

I feel that even if formal mandates shift, the scientific, ethical, and commercial imperative for inclusive trials remains strong.
Lya Rebelo, Commercial Enablement Manager, Citeline

Related resources

A female scientist in a lab coat holds a tube, conducting experiments in a laboratory setting.
MAY 07, 2024
Article
Clinical

Diversity at the Start: Best Practices for Clinical Trial Planning

Study sponsors should begin their clinical trial diversity efforts with a fit-for-purpose clinical protocol.

White paper cover for Practical Strategies for Ensuring a Diverse Patient Population in Clinical Trials
OCT 25, 2024
Whitepaper
Clinical

臨床試験における多様な患者集団を確保するための実践的戦略

臨床試験はますます複雑化しています。1試験あたりのエンドポイント数、手順数、実施施設数はいずれも増加しています。これにより、患者募集、特に多様な患者層の募集がより困難になっています。Citelineの専門家が、こうした募集上の課題を克服するためのヒントを共有します。

global diversity-resource-card-thumbnail
NOV 06, 2023
Article
Clinical

Clinical Trial Diversity on a Global Scale

Reporting clinical trial racial and ethnic data is a crucial step toward clinical trial diversity. But these definitions can be different across countries.

Darkened Qualified calendar. Please allow all cookies to use functionality.

To enable the booking feature, please enable all cookies in your browser.